SAN DIEGO, California ― For patients with moderate to severe rheumatoid arthritis whose condition is refractory to methotrexate, pain relief is better with the JAK inhibitor baricitinib than with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results